http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1847275-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67f8f7c227a5280128c81dad369fdf44
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31c37fb6c4fe6fce7948196ccf46a9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4305dc1a10babf1d53b5d77dd5b61e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b909a673bfd34f1ee514f9bb01b8540e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1d9c999bb7f02a0554de97f60bc95c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426020b03d8076f48d320b7423ef7b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a34f65cea6d834a91ae6b2125941766a
publicationDate 2008-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1847275-A4
titleOfInvention PLASMIDIC ADJUVANT FOR HIGH INTENSITY FOCUSED ULTRASONIC TREATMENT AND USE THEREOF
abstract A plasmid adjuvant that can increase the energy deposition of the target region when conducting HIFU therapy and si in the form of a biocompatible nanometer solid. Another adjuvant for HIFU therapyof the invention includes a discontinuous phase consisting of film-forming materials and a continuous phase consisting of aqueous medium, wherein the discontinuous phase is evenly dispersed in the continuous phase, the particle size of the discontinuous phase is 10-1000 nm, the amount of the film-forming materials in the adjuvant is 0.1-100 g/L, and the core materials is a biocompatible nanometer solid chosen from magnetic materials, hydroxyapatite and calcium carbonate and its amount in the adjuvant is 0.1150 g/L. The plasmid adjuvant fot HIFU therapy improves significantly the sound environment of target regions, increases the energy deposition of the target regions when conducting HIFU therapy, and consequently, enhances evidently the clinical effects of HIFU against tumor cells. It also provides the use of plasmid adjuvant fot HIFU during the process of the HIFU therapy.
priorityDate 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6088613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1842560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6551576-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112

Total number of triples: 34.